메뉴 건너뛰기




Volumn 31, Issue 8, 2008, Pages 546-547

Acid-related diseases. Are there more effective higher doses of proton pump inhibitors for the treatment of Helicobacter pylori infection?;Enfermedades relacionadas con el ácido. ¿Son más eficaces dosis más elevadas de inhibidores de la bomba de protones para el tratamiento de la infección por Helicobacter pylori?

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PLACEBO; PROTON PUMP INHIBITOR;

EID: 59949098472     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1157/13127103     Document Type: Note
Times cited : (30)

References (6)
  • 1
    • 24844431657 scopus 로고    scopus 로고
    • Effects of new triple therapy regimens of inhibition of gastric acid secretion and eradication of Helicobacter pylori in a randpmized trial
    • Murakami K, Sato R, Kubota T, Fujioka T, Nasu M. Effects of new triple therapy regimens of inhibition of gastric acid secretion and eradication of Helicobacter pylori in a randpmized trial. Gastroenterology. 1999;116:260A.
    • (1999) Gastroenterology , vol.116
    • Murakami, K.1    Sato, R.2    Kubota, T.3    Fujioka, T.4    Nasu, M.5
  • 2
    • 0142249447 scopus 로고    scopus 로고
    • Meta-analysis: Proton pump inhibitors vs. H2-receptor antagonists: their efficacy with antibiotics in Helicobacter pylori eradication
    • Gisbert JP, Khorrami S, Calvet X, Gabriel R, Carballo F, Pajares JM. Meta-analysis: proton pump inhibitors vs. H2-receptor antagonists: their efficacy with antibiotics in Helicobacter pylori eradication. Aliment Pharmacol Ther. 2003;18:757-66.
    • (2003) Aliment Pharmacol Ther , vol.18 , pp. 757-766
    • Gisbert, J.P.1    Khorrami, S.2    Calvet, X.3    Gabriel, R.4    Carballo, F.5    Pajares, J.M.6
  • 3
    • 33745524102 scopus 로고    scopus 로고
    • The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: A meta-analysis
    • Padol S, Yuan Y, Thabane M, Padol IT, Hunt RH. The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis. Am J Gastroenterol. 2006;101:1467-75.
    • (2006) Am J Gastroenterol , vol.101 , pp. 1467-1475
    • Padol, S.1    Yuan, Y.2    Thabane, M.3    Padol, I.T.4    Hunt, R.H.5
  • 4
    • 34547591122 scopus 로고    scopus 로고
    • Evidence that the degree and duration of acid suppression are related to Helicobacter pylori eradication by triple therapy
    • Sugimoto M, Furuta T, Shirai N, Kodaira C, Nishino M, Ikuma M, et al. Evidence that the degree and duration of acid suppression are related to Helicobacter pylori eradication by triple therapy. Helicobacter. 2007;12:317-23.
    • (2007) Helicobacter , vol.12 , pp. 317-323
    • Sugimoto, M.1    Furuta, T.2    Shirai, N.3    Kodaira, C.4    Nishino, M.5    Ikuma, M.6
  • 5
    • 30344474594 scopus 로고    scopus 로고
    • What is potent acid inhibition, and how can it be achieved?
    • Calvet X, Gomollon F. What is potent acid inhibition, and how can it be achieved? Drugs. 2005;65 Suppl 1:13-23.
    • (2005) Drugs , vol.65 , Issue.SUPPL. 1 , pp. 13-23
    • Calvet, X.1    Gomollon, F.2
  • 6
    • 59949088823 scopus 로고    scopus 로고
    • Las dosis altas de IBP aumentan la eficacia del tratamiento erradicador de H. pylori con terapia triple. Revisión sistemática y meta-análisis.
    • Villoria A, Calvet X, García P, Gisbert JP, Puig V. Las dosis altas de IBP aumentan la eficacia del tratamiento erradicador de H. pylori con terapia triple. Revisión sistemática y meta-análisis. Gastroenterol Hepatol. 2008;31:148.
    • (2008) Gastroenterol Hepatol , vol.31 , pp. 148
    • Villoria, A.1    Calvet, X.2    García, P.3    Gisbert, J.P.4    Puig, V.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.